替米沙坦对慢性心力衰竭患者血栓前状态的影响  被引量:3

Effect of telmisartan on prethrombotic state in congestive heart failure

在线阅读下载全文

作  者:刘应才[1] 彭永权[1] 王艳[1] 薛莉[1] 

机构地区:[1]四川泸州医学院附属医院心内科,四川泸州646000

出  处:《中国现代医学杂志》2006年第1期120-122,共3页China Journal of Modern Medicine

摘  要:目的观察替米沙坦对慢性充血性心力衰竭血栓前状态的影响。方法将45例慢性充血性心力衰竭患者随机分为替米沙坦组和对照组,替米沙坦组口服替米沙坦80mg,每天1次,共2周。对照组除不服用替米沙坦外,其他用药与替米沙坦相同。治疗前和治疗2周后测量2组血浆tPA、PAI活性,以及D-二聚体(D-D)和VWF水平。结果替米沙坦组和对照组在治疗前血浆tPA、PAI活性、D-二聚体(D-D)和VWF水平差异无显著性(P>0.05)。替米沙坦组治疗后血浆tPA活性显著性增高(P<0.05),血浆PAI活性、D-D和VWF水平均有显著性下降(P<0.05),而对照组却无显著性改变(P>0.05)。组间比较发现,替米沙坦组治疗后血浆PAI活性、D-D和VWF水平比对照组更低(P<0.05),而血浆tPA活性却无显著性增高(P>0.05)。结论短期口服替米沙坦可以明显改善CHF患者的血栓前状态,这可能与其降低CHF的栓塞危险和改善其预后有关。[Objective] To study the effect of Telmisartan on the prethmmbotic state in congestive heart failure (CHF). [Methods] 45 patients in CHF were divided randomly into Telmisartan group(Micardis 80 mg qd×14 days ) and Control group, Control group did not administrate Telmisartan, the other drugs were same as Telmisartan group. Tissue plasminogen activator activity (tPA), tissue plasminogen activator inhibitor-1 activity (PAI-1), Plasma D- dimer (D-D) and von Willebrand factor (vWF) level were measured in 2 group CHF patients with heart function class Ⅱ to IV before and 2 weeks after administration. [Results] Plasma tPA, PAI-1, vWF and D-D level before drug administration were not significantly different between 2 groups (P 〉0.05). Plasma tPA activity after drug administration in Telmisartan group was higher (P 〈0.05), but Plasma PAI-1, vWF and D-D level were significantly lower (P 〈0.05), and the level of above all indexes in control group were not significantly decreased after administration (P〉0.05). Compared with control group, plasma PAI-1, vWF and D-D level after drug administration in telmisartan group were significantly lower (P 〈0.05), but plasma tPA activity was not significantly increased (P 〉 0.05). [Conclusion] Telmisartan can improve the prethrombotic state in congestive heart failure, which may be correlated with decreasement of thrombembolia and death risk in CHF patients.

关 键 词:心力衰竭 血栓前状态 替米沙坦 

分 类 号:R641.61[医药卫生—外科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象